Article Versions Notes

Pagnuzzi-Boncompagni M, Picco V, Vial V, Planas-Bielsa V, Vandenberghe A, Daubon T, Derieppe M-A, Montemagno C, Durivault J, Grépin R, et al. Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma. Cancers. 2022; 14(1):70. https://doi.org/10.3390/cancers14010070

Pagnuzzi-Boncompagni, Marina, Vincent Picco, Valérie Vial, Victor Planas-Bielsa, Ashaina Vandenberghe, Thomas Daubon, Marie-Alix Derieppe, Christopher Montemagno, Jérôme Durivault, Renaud Grépin, and et al. 2022. "Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma" Cancers 14, no. 1: 70. https://doi.org/10.3390/cancers14010070

Pagnuzzi-Boncompagni, M., Picco, V., Vial, V., Planas-Bielsa, V., Vandenberghe, A., Daubon, T., Derieppe, M. -A., Montemagno, C., Durivault, J., Grépin, R., Martial, S., Doyen, J., Gavard, J., & Pagès, G. (2022). Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma. Cancers, 14(1), 70. https://doi.org/10.3390/cancers14010070